7 min read ยท Last updated September 28, 2026
- A copay card and a patient assistance program are two different benefits from the same drug company. A copay card lowers what an insured patient owes at the pharmacy counter; a patient assistance program gives the drug away free to people the card legally cannot help.
- Copay cards almost always exclude Medicare and Medicaid patients by design, because federal fraud law treats a coupon tied to a federal-program claim as an inducement. The U.S. Department of Health and Human Services’ Office of Inspector General has said so directly since 2014.
- Manufacturer patient assistance programs commonly set eligibility around 300% of the Federal Poverty Level. For a household of three in 2026, that’s about $81,960 a year, not $27,320.
- Your prescriber’s office has to be involved in the application, whether that means a signed section on your own form or your doctor enrolling you directly through the manufacturer’s own portal. Budget time for that step before you can enroll.
A copay card and a patient assistance program are not the same benefit: the card discounts what an insured patient pays at checkout, while the assistance program gives the drug away free to patients the card legally cannot reach, including anyone on Medicare or Medicaid.
In this article
- The first week after diagnosis
- Why the copay card has a limit
- What a patient assistance program actually requires
- The mistake that delays approval
- What to do at 30, 60, and 90 days
- Frequently asked questions
Marisol’s rheumatologist called with the diagnosis on a Tuesday, and the specialty pharmacy called two days later with the price: $4,100 a month for the biologic infusion she’d need every four weeks, for as long as the disease stayed active. Her insurance qualified her for the manufacturer’s copay card, but the card was capped at $2,000 a year, which covered less than one month of the bill.
The first week after diagnosis
Call the specialty pharmacy or the manufacturer’s own patient-support line, printed on the drug’s packaging or its website, and ask directly: “Do you have a patient assistance program, separate from your copay card?” The two programs are usually run by different departments inside the same company, and a pharmacy that quotes you the copay card doesn’t always volunteer the second option.
If you have commercial insurance, ask specifically about the “underinsured” track, because manufacturers don’t treat commercial insurance the same way. Johnson & Johnson’s patient assistance program explicitly covers patients who are “uninsured or have inadequate coverage through commercial, employer-sponsored, or government coverage,” while Pfizer’s program is limited to patients who are uninsured or on public insurance like Medicare, not commercially insured patients regardless of coverage gaps.
Loop in your prescriber’s office immediately. Manufacturer patient assistance programs route enrollment through your prescriber in different ways, some with a signed prescriber section on your own form, others with your doctor’s office enrolling you directly through the manufacturer’s own portal, but none of them are paperwork you can complete alone.
Why the copay card has a limit
The U.S. Department of Health and Human Services (HHS), through its Office of Inspector General, has warned since 2014 that a manufacturer’s copay coupon counts as “remuneration offered to consumers to induce the purchase of specific items,” and when that purchase is later billed to Medicare or Medicaid, offering the coupon can violate the federal Anti-Kickback Statute. In plain terms: it isn’t that Medicare patients don’t deserve help, it’s that the card itself becomes a legal risk for the manufacturer once a federal program pays the claim. That is why almost every copay card carries language excluding patients on Medicare or Medicaid, while the manufacturer’s separate patient assistance program, a direct free-drug program rather than a discount on a billed claim, faces no such restriction.
What a patient assistance program actually requires
| Program | Income threshold | Who it covers | Prescriber signature required |
|---|---|---|---|
| Pfizer RxPathways | 300% of the Federal Poverty Level | Uninsured patients (12-month enrollment) and patients on public insurance who can’t afford the copay (enrolled through the end of the calendar year); not commercially insured patients | Yes |
| Johnson & Johnson patient assistance program | 300% of the Federal Poverty Level | Uninsured patients and patients with inadequate commercial, employer, or government coverage | Yes |
Translating that 300% threshold into real dollars using the 2026 federal poverty guidelines:
| Household size | 100% Federal Poverty Level (annual) | 300% threshold many programs use |
|---|---|---|
| 1 | $15,960 | $47,880 |
| 2 | $21,640 | $64,920 |
| 3 | $27,320 | $81,960 |
| 4 | $33,000 | $99,000 |
The mistake that delays approval
Don’t assume you can fill out the whole application yourself. Merck’s program requires a form “signed by the patient and physician/prescriber,” and Pfizer’s and Johnson & Johnson’s both involve your prescriber’s office directly in enrollment as well, whether through a signed section or the manufacturer’s own provider portal. A form missing that step typically sits waiting on a callback instead of being processed.
Don’t assume Medicare disqualifies you from everything. It disqualifies you from the copay card specifically, not from the manufacturer’s separate assistance program, which several companies, including Johnson & Johnson, explicitly welcome Medicare and Medicaid patients into.
Don’t give up after one manufacturer says your income is too high. Thresholds vary by company and sometimes by drug. NeedyMeds, a nonprofit directory that manufacturers including Pfizer point patients to directly, lists assistance programs by drug name, so you can check whether an alternate track exists before assuming no help is available.
What to do at 30, 60, and 90 days
At 30 days, confirm your enrollment period in writing. Pfizer’s program, for example, runs 12 months for uninsured patients but only through the end of the calendar year for insured patients, which means some enrollees have to re-apply as early as January.
At 60 days, tell the program immediately if your income or insurance status changes. Patient assistance programs typically re-verify eligibility rather than assuming it stays fixed for the full enrollment period.
At 90 days, if your dose or drug changes, check whether your existing enrollment still applies. A new prescription can require a new application even from the same manufacturer. If your insurer is also slow-walking the drug itself, the separate 72-hour prior-authorization clock runs alongside the patient assistance timeline, not instead of it.
Frequently asked questions
What’s the actual difference between a copay card and a patient assistance program? A copay card reduces what an insured patient owes at the pharmacy for a specific drug, usually with an annual dollar cap. A patient assistance program gives the drug away free directly from the manufacturer to patients who qualify by income, whether or not they have insurance, and it isn’t capped the same way a card is.
Can I use a manufacturer’s patient assistance program if I have Medicare? Often yes, even though the same manufacturer’s copay card almost certainly excludes you. Federal fraud law treats copay coupons differently from direct free-drug programs, so some patient assistance programs, including Johnson & Johnson’s, explicitly accept patients on Medicare or Medicaid.
Does my doctor have to fill out part of the application? Yes. Merck’s program requires a form signed by both the patient and the prescriber, and Pfizer’s and Johnson & Johnson’s both route enrollment through your prescriber’s office as well, whether through a signed section or the manufacturer’s own provider portal. Your application typically cannot be processed until that step is complete.
What if my income is too high for one manufacturer’s program? Income thresholds vary by manufacturer and sometimes by drug, commonly set around 300% of the Federal Poverty Level. If one program turns you down, ask your prescriber’s office or a nonprofit directory like NeedyMeds whether the same drug has an alternate assistance track before assuming no help exists.
Leave a Reply